System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Thibault Voron is an expert in Surgery at Hôpital Saint-Antoine (France). Thibault Voron has authored 151 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 3 of them ongoing. SLR score: 439 (community average: 125). How the SLR is computed.

LeadR Profile

Thibault Voron Hôpital Saint-Antoine France
439 ScienceLeadR Reputation 439

Unlock

Register Login
Network Map

Surgery

Subspecialties: Oncology - Gastroenterology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026
Source: PubMed

Assistance Publique - Hôpitaux de Paris

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 151

Citations

Citations: 4 128 1st author: 33 Last author: 8 Unique author: 3

Main journals

Ann Surg 10
Journal de chirurgie viscérale 9
Rev Prat 9
Ann Surg Oncol 8
Eur J Surg Oncol 7

Best Journals

J Clin Oncol 1
Lancet Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Textbook Outcomes and Survival in Gastric Cancer Surgery: Results of a French-Speaking Multicenter Study.
PMID 42746996 — achievement, disease-free survival, neoplasms, therapeutics, stomach neoplasms		World J Surg20260
Letter to the Editor Regarding "True Incidence of Appendiceal Neoplasms Among Patients Presenting with Complicated Appendicitis: A Call for a Revised Management Algorithm".
PMID 42474966 — appendiceal neoplasms, incidence, neoplasms, algorithms, appendicitis		Ann Surg Oncol20260
Impact of postoperative chemotherapy in patients resected for esophagogastric adenocarcinoma with major pathological response after preoperative chemotherapy: a study from the FREGAT database.
PMID 42466102 — neoplasms, adenocarcinoma, drug therapy, chemotherapy		Ther Adv Med Oncol20260
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting Stoma.
PMID 41886725 — leucovorin, hospitalization, neoplasms, drug therapy, oxaliplatin, fluorouracil, chemotherapy, adjuvant, therapeutics, medical oncology, colorectal neoplasms, capecitabine, chemotherapy		JCO Oncol Pract20260
Oncologic Risk of Missed Appendiceal Tumors in Acute Appendicitis.
PMID 41879758 — appendiceal neoplasms, surgical procedures, operative, neoplasms, polyps, cohort studies, appendectomy, wounds and injuries, appendicitis		JAMA Surg20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 2 2

By status:

Not yet recruiting 2
Completed 1
Recruiting 1
Terminated 1

By type:

Interventional 5

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer
NCT07408999 — thoracotomy, stomach, esophagus, celiac artery, lymph node excision, esophagogastric junction, thoracic duct, neoplasms, hepatic artery, arteries, lymph, robotic surgical procedures, morbidity, gastric artery, therapeutics, esophageal neoplasms, esophagectomy, splenic artery		N/ANot yet recruiting2026
Evaluation of Efficacy and Safety De escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma
NCT06933966 — safety, esophagogastric junction, neoplasms, adenocarcinoma, drug therapy, chemotherapy, adjuvant, therapeutics, esophageal neoplasms, chemotherapy		Phase 2Not yet recruiting2025
Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer
NCT05854368 — stomach, blood, neoplasms, precancerous conditions, biomarkers, blood volume, specimen handling, research, stomach neoplasms		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS